Our latest https://t.co/HK2W5Fs10c, led by fantastic Divya Vinjamur, is out in Nature Genetics: We found a new HbF regulator (ZNF410) with wide therapeutic index and unique molecular mechanism. Bauerlab is recruiting new members https://t.co/UacI65Qe6G! 1/7
The SECURE-SCD registry has been updated w/new cases of COVID-19 in patients w/sickle cell disease. https://t.co/4gNEPBqBlN
Providers all over the world can register their patients&help us understand the impact of COVID-19 on patients w/SCD. @CDCgov@ASH_hematology@SCDAAorg
Does Hydroxycarbamide (aka Hydroxyurea or HU) Exposure Decrease Cognitive Impairment Risk in Patients with Sickle Cell Disease? A study observed an association between HU and improved neurocognitive outcomes in adolescents with #SickleCell https://t.co/6rfK3vABrc
🚨 @molinahealth
Denied my #SickleCell patient “combination therapy”. She’s spent 20 days out of the last 60 in the hospital with pain.
I’m thrilled to do a peer to peer. My other patients can wait, I guess.
Maybe this time I’ll invoice you for teaching your employee.
"In the past five years, there has been very encouraging news on the #sicklecell disease drug development front. Now, there are a number of promising new therapies on the market, including hydroxyurea." #ConquerSCD https://t.co/HJs6z7Fg8M
Thank you Admiral Giroir for you commitment to advance #SickleCell programs! Together we can #ConquerSCD globally and reduced underage 5 mortality from SCD.
Les maladies tropicales négligées défigurent les personnes et les rendent moins productives. Cela signifie souvent faire face à la stigmatisation, la discrimination et l'exclusion sociale, qui pèsent lourdement sur la santé mentale. #BeatNTDs#WorldLeprosyDay2020@mwelentuli